Key factors underpinning neuroimmune-metabolic-oxidative (NIMETOX) major depression in outpatients: paraoxonase 1 activity, reverse cholesterol transport, increased atherogenicity, protein oxidation, and differently expressed cytokine networks. DOI Creative Commons
Michaël Maes, Ketsupar Jirakran, Laura de Oliveira Semeão

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: March 3, 2025

Abstract Background Major depressive disorder (MDD) is associated with neuro-immune – metabolic oxidative (NIMETOX) pathways. Aims To examine the connections among NIMETOX pathways in outpatient MDD (OMDD) and without syndrome (MetS); to determine prevalence of aberrations a cohort OMDD patients. Methods We included 67 healthy controls 66 patients we assessed various Results successfully identified subgroup individuals pathways, including diminished lecithin-cholesterol acyltransferase (LCAT), paraoxonase 1 (PON1) activity, reverse cholesterol transport (RCT) activities, elevated atherogenicity, differentially expressed immune networks, advanced oxidation protein products (AOPP). A large part variance (around 44%) atherogenicity indices was AOPP, fasting blood glucose (FBG), PON1 activation. LCAT activity positively correlated negatively FBG, AOPP RCT related R/R 192 genotype FBG larger overall severity (50.4%), suicidal behaviors (27.7%), neuroticism (42.1%) adverse childhood experiences immune-related neurotoxicity, insulin, inversely neuroprotection. Conclusions Many (78.8%) show The features OMDD, illness, neuroticism, behaviors, are caused by intertwined that may exert additional effects depending on whether MetS present or not.

Language: Английский

Key factors underpinning neuroimmune-metabolic-oxidative (NIMETOX) major depression in outpatients: paraoxonase 1 activity, reverse cholesterol transport, increased atherogenicity, protein oxidation, and differently expressed cytokine networks. DOI Creative Commons
Michaël Maes, Ketsupar Jirakran, Laura de Oliveira Semeão

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: March 3, 2025

Abstract Background Major depressive disorder (MDD) is associated with neuro-immune – metabolic oxidative (NIMETOX) pathways. Aims To examine the connections among NIMETOX pathways in outpatient MDD (OMDD) and without syndrome (MetS); to determine prevalence of aberrations a cohort OMDD patients. Methods We included 67 healthy controls 66 patients we assessed various Results successfully identified subgroup individuals pathways, including diminished lecithin-cholesterol acyltransferase (LCAT), paraoxonase 1 (PON1) activity, reverse cholesterol transport (RCT) activities, elevated atherogenicity, differentially expressed immune networks, advanced oxidation protein products (AOPP). A large part variance (around 44%) atherogenicity indices was AOPP, fasting blood glucose (FBG), PON1 activation. LCAT activity positively correlated negatively FBG, AOPP RCT related R/R 192 genotype FBG larger overall severity (50.4%), suicidal behaviors (27.7%), neuroticism (42.1%) adverse childhood experiences immune-related neurotoxicity, insulin, inversely neuroprotection. Conclusions Many (78.8%) show The features OMDD, illness, neuroticism, behaviors, are caused by intertwined that may exert additional effects depending on whether MetS present or not.

Language: Английский

Citations

0